Wednesday, April 25, 2018

Very Brief Blog: Dr. Elaine Jeter Joins Aegis Sciences as Policy Advisor

Dr. Elaine Jeter, the founding medical director of the CMS MolDx program, has joined Aegis Sciences as a Policy Advisor.  Press release below.   Dr. Jeter stepped down from her MolDx position in November 2016.

Dr. Elaine Jeter Joins Aegis Sciences Corporation as Senior Medical Policy Advisor

ASHVILLE, Tenn., April 24, 2018 (GLOBE NEWSWIRE) -- Aegis Sciences Corporation, a leading healthcare sciences and forensic toxicology laboratory, is pleased to announce that Dr. Elaine Jeter has joined the company as its Senior Medical Policy Advisor.

“I am delighted to welcome Dr. Elaine Jeter,” said Dr. Frank Basile, Aegis’s Chief Executive Officer. “Dr. Jeter’s wealth of experience in clinical medicine and Medicare will be very valuable to Aegis.”

As Senior Medical Policy Advisor, Dr. Jeter will assist with both regulatory and medical coverage policy engagement and compliance, new and existing Managed Care relationships, and development of appropriate evidence-based clinical utility evidence for Aegis’s new and innovative testing services.

In regards to her decision to serve as Aegis’s Senior Medical Policy Advisor, Dr. Jeter said, “I am excited to join the Aegis team in this critical role as it has and continues to maintain a pristine track record for quality, compliance and integrity in toxicology testing, which is manifest at all levels within the organization.”

Prior to joining Aegis, Dr. Jeter was the Senior Medical Director at Palmetto GBA, a Medicare Administrative Contractor that administers Medicare health insurance for the Centers for Medicare & Medicaid Services (CMS) throughout the U.S. At Palmetto GBA, Dr. Jeter developed and directed the MolDX program, which was created to uniquely identify laboratory tests, primarily sole-source and molecular tests, and to determine the clinical value of a test by way of a technical assessment. The assessments were subsequently developed into Medicare local coverage decision policies. In the field of toxicology, her “Controlled Substance Monitoring and Drugs of Abuse Testing” coverage policy has largely become the model across the country for providers and payers alike.   

Dr. Jeter has practiced surgical pathology and directed clinical laboratories in academia and the private practice. She completed her medical school and residency training at the Medical University of South Carolina (MUSC) in Charleston, SC. She is board certified in Anatomic and Clinical Pathology, with sub-specialty boards in Blood Banking and Transfusion Medicine.

About Aegis Sciences Corporation

Founded in 1990, Aegis Sciences Corporation is a laboratory sciences company based in Nashville, TN, that provides science-driven testing and consulting services for clients such as healthcare providers, pharmaceutical companies, professional and amateur sports organizations, leading college and university athletic programs, Fortune 500 corporations, and government agencies throughout the United States. For more information please visit